scholarly journals Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology

Viruses ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 451 ◽  
Author(s):  
Muhammad Bashir Bello ◽  
Khatijah Yusoff ◽  
Aini Ideris ◽  
Mohd Hair-Bejo ◽  
Abdurrahman Hassan Jibril ◽  
...  

Many traditional vaccines have proven to be incapable of controlling newly emerging infectious diseases. They have also achieved limited success in the fight against a variety of human cancers. Thus, innovative vaccine strategies are highly needed to overcome the global burden of these diseases. Advances in molecular biology and reverse genetics have completely restructured the concept of vaccinology, leading to the emergence of state-of-the-art technologies for vaccine design, development and delivery. Among these modern vaccine technologies are the recombinant viral vectored vaccines, which are known for their incredible specificity in antigen delivery as well as the induction of robust immune responses in the vaccinated hosts. Although a number of viruses have been used as vaccine vectors, genetically engineered Newcastle disease virus (NDV) possesses some useful attributes that make it a preferable candidate for vectoring vaccine antigens. Here, we review the molecular biology of NDV and discuss the reverse genetics approaches used to engineer the virus into an efficient vaccine vector. We then discuss the prospects of the engineered virus as an efficient vehicle of vaccines against cancer and several infectious diseases of man and animals.

2017 ◽  
Vol 260 ◽  
pp. 91-97 ◽  
Author(s):  
Shobana Raghunath ◽  
Raghavendra Sumanth Pudupakam ◽  
Adria Allen ◽  
Moanaro Biswas ◽  
Nammalwar Sriranganathan

2007 ◽  
Vol 67 (17) ◽  
pp. 8285-8292 ◽  
Author(s):  
Adam Vigil ◽  
Man-Seong Park ◽  
Osvaldo Martinez ◽  
Mark A. Chua ◽  
Sa Xiao ◽  
...  

2020 ◽  
Vol 22 (1) ◽  
Author(s):  
Amin Tavassoli ◽  
Safoura Soleymani ◽  
Alireza Haghparast ◽  
Gholamreza Hashemi Tabar ◽  
Mohammad Reza Bassami ◽  
...  

BioTechniques ◽  
2020 ◽  
Vol 68 (2) ◽  
pp. 96-100
Author(s):  
Pheik-Sheen Cheow ◽  
Tiong Kit Tan ◽  
Adelene Ai-Lian Song ◽  
Khatijah Yusoff ◽  
Suet Lin Chia

Reverse genetics has been used to generate recombinant Newcastle disease virus with enhanced immunogenic properties for vaccine development. The system, which involves co-transfecting the viral antigenomic plasmid with three helper plasmids into a T7 RNA polymerase-expressing cell to produce viral progenies, poses a great challenge. We have modified the standard transfection method to improve the transfection efficiency of the plasmids, resulting in a higher titer of virus progeny production. Two transfection reagents (i.e., lipofectamine and polyethylenimine) were used to compare the transfection efficiency of the four plasmids. The virus progenies produced were quantitated with flow cytometry analysis of the infectious virus unit. The modified transfection method increased the titer of virus progenies compared with that of the standard transfection method.


2019 ◽  
Vol 14 (9) ◽  
pp. 617-628 ◽  
Author(s):  
Aidin Molouki ◽  
Abdou Nagy

Two decades have passed since the first reverse genetics system for the rescue of recombinant Newcastle disease virus was developed. Since then, the recombinant Newcastle disease virus vector has shown promising results as a safe and potent vector for development of many vaccines for both avian and human use. Herein, we review several technical topics that would be useful to further understanding of this technology. First, the effect of using helper plasmids encoding proteins belonging to strains other than the full-length cDNA and the possible incorporation of these expressed proteins into progeny virus will be discussed. Then, we will discuss the effect of removal of additional G residues from the T7 initiation sequence and finally, we will review different ways to improve rescue efficiency.


2004 ◽  
Vol 78 (8) ◽  
pp. 4176-4184 ◽  
Author(s):  
Zhuhui Huang ◽  
Aruna Panda ◽  
Subbiah Elankumaran ◽  
Dhanasekaran Govindarajan ◽  
Daniel D. Rockemann ◽  
...  

ABSTRACT The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) plays a crucial role in the process of infection. However, the exact contribution of the HN gene to NDV pathogenesis is not known. In this study, the role of the HN gene in NDV virulence was examined. By use of reverse genetics procedures, the HN genes of a virulent recombinant NDV strain, rBeaudette C (rBC), and an avirulent recombinant NDV strain, rLaSota, were exchanged. The hemadsorption and neuraminidase activities of the chimeric viruses showed significant differences from those of their parental strains, but heterotypic F and HN pairs were equally effective in fusion promotion. The tissue tropism of the viruses was shown to be dependent on the origin of the HN protein. The chimeric virus with the HN protein derived from the virulent virus exhibited a tissue predilection similar to that of the virulent virus, and vice versa. The chimeric viruses with reciprocal HN proteins either gained or lost virulence, as determined by a standard intracerebral pathogenicity index test of chickens and by the mean death time in chicken embryos (a measure devised to classify these viruses), indicating that virulence is a function of the amino acid differences in the HN protein. These results are consistent with the hypothesis that the virulence of NDV is multigenic and that the cleavability of F protein alone does not determine the virulence of a strain.


2021 ◽  
Author(s):  
kai zhao ◽  
Beini Sun ◽  
Ci Shi ◽  
Yanwei Sun ◽  
Zheng Jin ◽  
...  

Abstract Background: There is a great interest to develop strategies for enhancing antigen delivery to mucosal immune system as well as to identify mucosal active immunostimulating agents. To elevate the potential of O -2′-Hydroxypropyl trimethyl ammonium chloride chitosan (O-2′-HACC) nanoparticles as adjuvant and mucosal immune delivery carrier for DNA vaccine, we prepared the O-2′-HACC nanoparticles loaded with Newcastle disease virus F gene plasmid DNA with C3d6 molecular adjuvant (O-2′-HACC/pFDNA). Results: The O-2′-HACC/pFDNA had regular spherical morphology with a particle size of 202.3±0.52 nm, zeta potential of 50.8±8.21 mV, encapsulation efficiency of 90.74±1.10 %, and loading capacity of 49.84±1.20 %. The plasmid DNA could be sustainably released from the O-2′-HACC/pFDNA after an initial burst release. Intranasal vaccination of chickens immunized with O-2′-HACC/pFDNA not only induced higher anti-NDV IgG and sIgA antibody titers, but also significantly promoted lymphocyte proliferation and produced the higher levels of IL-2, IL-4, IFN-γ, CD4+ and CD8+ T lymphocytes than the NDV commercial attenuated live vaccine. Intranasal delivery of the O-2′-HACC/pFDNA enhanced humoral, cellular and mucosal immune responses, and protected chickens from the infection of highly virulent NDV than intramuscular delivery. Conclusions: This study indicated that the O-2′-HACC nanoparticles could be used as vaccine adjuvant and delivery system for mucosal immunity and have an immense application promise.


2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Yang Zhao ◽  
Huairan Liu ◽  
Feng Cong ◽  
Wei Wu ◽  
Ran Zhao ◽  
...  

Newcastle disease (ND), caused by Newcastle disease virus (NDV), is highly contagious and represents a major threat to the poultry industry. The thermostable vaccines are not insensitive to heat and ease of storage and transportation, but the mechanism of NDV thermostability remains unknown. The phosphoprotein (P), fusion protein (F), hemagglutinin-neuraminidase protein (HN), and large polymerase protein (L) are associated with NDV virulence. The association between F, HN, or L and viral thermostability has been, respectively, studied in different reports. However, the effects of P on NDV thermostability have not been demonstrated. Here, we utilized an existing reverse genetics system in our laboratory, to generate chimeric viruses by exchanging the P protein between the thermostable NDV4-C strain and the thermolabile LaSota strain. Chimeric viruses were found to possess similar growth properties, passage stability, and virulence, as compared to those of these parental strains. Interestingly, the thermostability of the chimera with P derived from the thermolabile LaSota strain was reduced compared to that of the parental virus, and P of the thermostable NDV4-C strain enhanced chimeric virus thermostability. Our data demonstrate that P is an important factor for the thermostability of NDV and provides information regarding the molecular mechanism of NDV thermostability; moreover, these results suggest a theoretical basis for using the NDV4-C strain as a thermostable vaccine.


Sign in / Sign up

Export Citation Format

Share Document